Position in UTHR
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$45,741,289
+$1,430,775 QoQ
Shares Held
77,138
-15.2% QoQ
Ownership
0.182%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.25198994010735.ToString("F0")%
Shared 0.ToString("F0")%
None 0.7480100598926599.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Derivatives in UTHR
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$3,735,550
PutShares
13,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $924,834,595 across 59 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,491,173 | $649,111,558 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
77,138 | $45,741,289 | |
| 3 | HLN |
Haleon plc
|
4,022,749 | $40,267,716 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
231,311 | $30,472,908 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,136,022 | $21,039,125 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
805,422 | $19,273,746 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
300,133 | $17,788,881 | |
| 8 | VTRS |
Viatris Inc
|
1,160,097 | $15,672,908 |
All Filings in UTHR
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $45,741,289 | 77,138 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $44,310,514 | 90,940 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $32,749,103 | 78,121 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $30,955,063 | 107,726 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $3,735,550 | 13,000 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $22,835,714 | 74,077 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $26,911,105 | 76,270 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $27,311,643 | 76,215 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $27,123,575 | 85,147 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $14,578,718 | 63,463 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $10,384,083 | 47,224 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $12,311,042 | 54,505 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $11,836,392 | 53,619 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $11,992,161 | 53,546 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $13,664,229 | 49,136 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $15,416,646 | 73,630 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $15,403,078 | 65,367 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $17,913,548 | 99,847 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $17,703,865 | 81,932 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $79,757,568 | 432,103 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $49,481,992 | 275,804 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $57,639,565 | 344,590 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $46,254,356 | 304,726 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $33,913,073 | 335,773 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $51,718,909 | 427,429 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $5,007,781 | 52,808 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||